Allogeneic haematopoietic stem cell transplantation: current status and future outlook.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  British Medical Bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/BMB/LDL005PMID 16968691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe.

  2006cited by this paper
• Strategies for widening the use of cord blood in hematopoietic stem cell transplantation.

  2006cited by this paper
• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  2006cited by this paper
• Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis

  2005cited by this paper
• Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning

  2005cited by this paper
• Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation

  2005cited by this paper
• Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation.

  2005cited by this paper
• New trends in umbilical cord blood transplantation.

  2005cited by this paper
• Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

  2004cited by this paper
• Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.

  2004cited by this paper
• Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?

  2004cited by this paper
• Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.

  2004cited by this paper
• Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

  2003cited by this paper
• Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?

  2003cited by this paper
• Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.

  2003cited by this paper
• Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: A Pediatric Blood and Marrow Transplant Consortium study

  2003cited by this paper
• Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.

  2002cited by this paper
• Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors

  2002cited by this paper
• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

  2001cited by this paper
• Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases

  2001cited by this paper
• Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.

  2001cited by this paper
• T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation.

  2001cited by this paper
• Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

  2001cited by this paper
• Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia.

  2000cited by this paper
• Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

  2000cited by this paper
• Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

  2000cited by this paper
• Pathophysiologic mechanisms of acute graft-vs.-host disease.

  1999cited by this paper
• Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia

  1999cited by this paper
• Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.

  1999cited by this paper
• Increased Risk of Chronic Graft-Versus-Host Disease, Obstructive Bronchiolitis, and Alopecia With Busulfan Versus Total Body Irradiation: Long-Term Results of a Randomized Trial in Allogeneic Marrow Recipients With Leukemia

  1999cited by this paper
• Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.

  1999cited by this paper
• Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.

  1998cited by this paper
• Allogeneic peripheral blood stem cell transplantation.

  1996cited by this paper
• Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.

  1993cited by this paper
• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.

  1990cited by this paper
• Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.

  1990cited by this paper
• Graft-versus-leukemia reactions after bone marrow transplantation.

  1990cited by this paper
• Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen

  1987cited by this paper
• Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen.

  1987cited by this paper
• One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

  1977cited by this paper
• Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome.

  1968cited by this paper
• Transplantation

  1963cited by this paper
• Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy.

  1957cited by this paper

• Effects of FOLFOX Chemotherapy on Tumor Oxygenation and Perfused Vasculature: An In Vivo Study by Optical Techniques

  2024cites this paper
• Stem Cells: DNA Microarray Approach

  2023cites this paper
• A NIGHTMARE FOR TRANSPLANT PHYSICIANS: BONE MARROW DONOR CANDIDATES WITHDRAWING FROM THE DONATION PROCESS

  2022cites this paper
• Hematopoietic Stem Cell Transplantation, Where Have We Come and Where Do We Go.

  2020cites this paper
• FTY720 ameliorates GvHD by blocking T lymphocyte migration to target organs and by skin fibrosis inhibition

  2020cites this paper
• The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.

  2019cites this paper
• Chapter 5 References

  2017cites this paper
• Hsp90 inhibition ameliorates CD4+ T cell‐mediated acute Graft versus Host disease in mice

  2016influential citation
• Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns

  2016cites this paper
• Detection of BCR/ABL Translocation in Bone Marrow Derived Mesenchymal Stem Cells in Egyptian CML Patients

  2015cites this paper
• In vitro polyclonal activation of conventional T cells with a CD28 superagonist protects mice from acute graft versus host disease

  2015cites this paper
• Antibody- and aptamer-strategies for GvHD prevention

  2014cites this paper
• Hematopoetic stem cell transplantation in children.

  2014cites this paper
• Peripheral blood stem cell transplantation in a significant body weight difference between a smaller donor and a larger recipient: a case report.

  2013influential citation
• Novel interferon-based pre-transplantation conditioning in the treatment of a congenital metabolic disorder.

  2013cites this paper
• Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis

  2012cites this paper
• Total body irradiation conditioning for bone marrow transplantation

  2012cites this paper
• Development of Novel Cell Fate Control Gene Therapy for Applications in Cancer and Immune Disorders

  2012cites this paper
• Proteasomes, TAP, and Endoplasmic Reticulum-Associated Aminopeptidase Associated with Antigen Processing Control CD4+ Th Cell Responses by Regulating Indirect Presentation of MHC Class II-Restricted Cytoplasmic Antigens

  2011cites this paper
• Characterization of a New Mouse Model for Peripheral T Cell Lymphoma in Humans

  2011cites this paper
• Neovascularization in a mouse model via stem cells derived from human fetal amniotic membranes

  2011cites this paper
• Toleranzinduktion oder Immunsuppression zur Verhinderung von insbesondere Transplantat-Wirt-Reaktion (GvHD) durch kurzzeitige Vorinkubation von transplantierten Zellsuspensionen, Geweben oder Organen, die mit Liganden zu Zelloberflächenmolekülen beschichtet sind

  2010cites this paper
• Facing haematopoietic stem‐cell transplantation: do patients and their physicians agree regarding the prognosis?

  2010cites this paper
• Hematopoetic stem cell transplantation in children

  2010cites this paper
• Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment

  2009cites this paper
• Infectious complications after allogeneic stem cell transplantation: incidence in matched‐related and matched‐unrelated transplant settings

  2009cites this paper
• Novel application of lentiviral vectors towards treatment of graft-versus-host disease

  2009cites this paper
• Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease.

  2009cites this paper
• Mental status changes after hematopoietic stem cell transplantation

  2009cites this paper
• CNS complications of hematopoietic stem cell transplantation.

  2009cites this paper
• Impending challenges in the hematopoietic stem cell transplantation physician workforce.

  2009cites this paper
• Relationship between tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single center prospective study.

  2009cites this paper
• Induction of Tolerance Through Mixed Chimerism for Composite Tissue Allotransplantation: Insights, Problems and Solutions

  2008cites this paper
• [Neurological complications of transplantation].

  2008cites this paper
• Efforts of the United States’ National Marrow Donor Program and Registry to improve utilization and representation of minority donors

  2008cites this paper
• CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair

  2008cites this paper
• Expanded CD34+ Human Umbilical Cord Blood Cells Generate Multiple Lymphohematopoietic Lineages in NOD-scid IL2rγ null Mice

  2008cites this paper
• Cyclosporine A can induce DNA double strand breaks: implications for bone marrow transplantation regimens particularly for individuals with defective DNA repair.

  2008cites this paper
• Physicians' prognostic estimates of survival for patients undergoing allogeneic hematopoietic stem cell transplantation.

  2008cites this paper
• Optimization of total body irradiation: the match between (maximal) leukemic cell kill and (minimal) late effects

  2007cites this paper
• STUDIES OF SPECIFIC IMMUNITY AGAINST VIRAL INFECTIONS AFTER STEM CELL TRANSPLANTATION

  2007cites this paper
• Stem cells: therapeutic present and future.

  2007cites this paper